Rapid and efficient screening of Alzheimer's disease β-amyloid inhibitors using label-free gold nanoparticles.
Herein we report that a visual, label-free gold nanoparticle-based assay for rapid and efficient screening of Alzheimer's disease β-amyloid inhibitors.